LobbyingProton Therapy Consortium Fka National Association for Proton Therapy lobbying by quarter
Proton Therapy Consortium Fka National Association for Proton Therapy's latest lobbying report covers Q4 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Proton Therapy Consortium Fka National Association for Proton Therapy
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$0 · 8 reports
- Health issues$0 · 8 reports
- Insurance$0 · 8 reports
- Medicare and Medicaid$0 · 8 reports
- Medical research and clinical labs$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)8 reports
- HOUSE OF REPRESENTATIVES8 reports
- SENATE8 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseProton Therapy Consortium Fka National Association for Proton Therapy | $0 | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER ROGERS MAGGIORE | Executive Director | Q3 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/10/02for Q4 2024 | In-house | Under $5,000 |
| 24/10/02for Q3 2024 | In-house | Under $5,000 |
| 24/07/03for Q2 2024 | In-house | Under $5,000 |
| 24/04/26for Q1 2024 | In-house | Under $5,000 |
| 23/12/22for Q4 2023 | In-house | Under $5,000 |
| 23/11/20for Q3 2023 | In-house | Under $5,000 |
| 23/07/10for Q2 2023 | In-house | Under $5,000 |
| 23/06/28for Q1 2023 | In-house | Under $5,000 |
| 23/01/31for Q4 2022 | In-house | Under $5,000 |